Advertisement
OtherChemotherapy, Antibiotics, and Gene Therapy

A mathematical model to investigate the effects of ceralasertib and olaparib in targeting the cellular DNA Damage responses pathway

Kira Pugh, Michael Davies and Gibin Powathil
Journal of Pharmacology and Experimental Therapeutics June 30, 2023, JPET-AR-2022-001558; DOI: https://doi.org/10.1124/jpet.122.001558

Article Information

JPET-AR-2022-001558
DOI 
https://doi.org/10.1124/jpet.122.001558
PubMed 
37391224
Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0022-3565
Online ISSN 
1521-0103
History 
  • Published online June 30, 2023.

Article Versions

Copyright & Usage 
Copyright © 2023 American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Kira Pugh1,*,
  2. Michael Davies2, and
  3. Gibin Powathil1,*
  1. 1Swansea University, United Kingdom
  2. 2AstraZeneca, United Kingdom
  1. ↵* Corresponding Author:
    Gibin Powathil, Swansea University, United Kingdom. E-mail: g.g.powathil{at}swansea.ac.uk
  2. * Corresponding Author; email: k.a.pugh{at}swansea.ac.uk

Statistics from Altmetric.com

Article usage

Article usage: June 2023 to November 2023

AbstractFullPdf
Jun 20231802
Jul 20232670111
Aug 2023135060
Sep 20232102537
Oct 20235036188
Nov 2023157446

Back to top

In this issue

Download PDF
Article Alerts
Email Article
Citation Tools

OtherChemotherapy, Antibiotics, and Gene Therapy

Modelling the effects of DNA Damage Response Inhibitor Drugs

Kira Pugh, Michael Davies and Gibin Powathil
Journal of Pharmacology and Experimental Therapeutics June 30, 2023, JPET-AR-2022-001558; DOI: https://doi.org/10.1124/jpet.122.001558
Reddit logo Twitter logo Facebook logo Mendeley logo

Jump to section

Advertisement